News

A unanimous panel, including the FDA commissioner, says the black box warnings are outdated and need to be removed by the FDA ...
Botanic Tonics defends its kratom products as safe, asserting they are not affected by the FDA's crackdown focused on ...
In our Venable FDA Pulse series, we report on critical developments within the Food and Drug Administration (FDA or the Agency) that may affect ...
The end of the IV saline shortage follows another removal from the FDA’s shortage list in mid-July. Then, the agency removed ...
On July 29, he was removed from his role after some conservative figures such as far-right activist and conspiracy theorist Laura Loomer criticized his approach to drug approvals and his past ...
President Trump’s effort to lessen crime in Washington, D.C., and launch a “beautification” effort is clashing with a long tradition of Republicans criticizing and outright writing off the ...
Vinay Prasad resumes leadership at the FDA’s CBER two weeks after he resigned amid cell and gene therapy controversy.
The nationwide shortage of critical intravenous saline fluid triggered by Hurricane Helene is over, though some other ...
The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.
The Resident opens the door for Chastain Park Memorial Hospital, granting us a raw, unflinching glimpse of the moral challenges, administrative hurdles, and personal existence suffered by medical prof ...
WASHINGTON, DC – Dr. Vinay Prasad has been reinstated to a senior position at the Food and Drug Administration, according to ...
The shares of biotech companies fell after news that ousted regulator Vinay Prasad is set to go back to the US Food and Drug Administration. Prasad had previously overruled his own scientific review ...